Could a common diabetes drug be the key to better stroke recovery?

NCT ID NCT07613437

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) can reduce brain swelling and improve recovery in people who have had a bleeding stroke. About 200 adults with a specific type of brain bleed will receive either standard care or the drug plus standard care. The goal is to see if the drug limits secondary brain injury and leads to better function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chinese University of Hong Kong

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of University of Science and Technology China

    Hefei, Anhui, China

    Contact Email: •••••@•••••

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

    Contact Email: •••••@•••••